Question to the Department of Health and Social Care:

To ask Her Majesty's Government, in the context of the medication and error programme outlined in the Report of the Short Life Working Group on reducing medication-related harm, how many additional phases will be developed as part of the medicines safety dashboard being developed by NHS Digital and the NHS Business Services Authority.

The intention is to develop a second phase of indicators covering other medicines, risks of harm and reasons for admission. At this point the number of indicators is not yet agreed nor timescale for publication, but publication is likely to be before the end of 2018.